Manufacturer of Controlled Substances; Notice of Registration, 10676-10677 [05-4205]
Download as PDF
<![CDATA[
10676
Federal Register / Vol. 70, No. 42 / Friday, March 4, 2005 / Notices
Drug
Schedule
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
4-Methoxyamphetamine (7411) ...
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Codeine (9050) .............................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Methadone (9250) ........................
Methadone Intermediate (9254) ...
Morphine (9300) ...........................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
I
I
I
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cambrex North Brunswick, Inc.,
Technology Centre of New Jersey to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Cambrex North Brunswick,
Inc., Technology Centre of New Jersey to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
DEPARTMENT OF JUSTICE
By Notice dated September 16, 2004,
and published in the Federal Register
on September 30, 2004, (69 FR 58539–
58540), Cambridge Isotope Laboratory,
50 Frontage Road, Andover,
Massachusetts 01810, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
Schedules I and II:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated September 28, 2004
and published in the Federal Register
on October 14, 2004, (69 FR 61043),
Cambrex North Brunswick, Inc.,
Technology Center of New Jersey, 661
Highway One, North Brunswick, New
Jersey 08902, made application by
renewal to the Drug Enforcement
Jkt 205001
BILLING CODE 4410–09–P
Manufacturer of Controlled
Substances; Notice of Registration
BILLING CODE 4410–09–P
19:07 Mar 03, 2005
Dated: February 23, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–4235 Filed 3–3–05; 8:45 am]
Drug Enforcement Administration
Dated: February 23, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–4212 Filed 3–3–05; 8:45 am]
VerDate jul<14>2003
Administration (DEA) to be registered as
an importer of Phenylacetone (8501), a
basic class of controlled substance listed
in Schedule II.
The company plans to import the
listed controlled substances to
manufacture amphetamine.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. sections 823(a) and
952(a) and determined that the
registration of Cambrex North
Brunswick, Inc. to import the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Cambrex North Brunswick, Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
sections 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the
above named company is granted
registration as an importer of the basic
class of controlled substance listed.
Drug
Schedule
Methaqualone (2565) ...................
Dimethyltryptamine (7435) ...........
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
I
I
II
II
II
II
Drug
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Benzoylecgonine (9180) ...............
Methadone (9250) ........................
Dextropropoxyphene (9273) .........
Morphine (9300) ...........................
Fentanyl (9801) ............................
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances to produce isotope labeled
standards for drug analysis.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cambridge Isotope Laboratory to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Cambridge Isotope
Laboratory to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: February 22, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–4204 Filed 3–3–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated September 28, 2004,
and published in the Federal Register
on October 14, 2004, (69 FR 61043),
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78664, made application by renewal to
the Drug Enforcement Administration
(DEA) for registration as a bulk
manufacturer of the basic classes of
controlled substances listed in
Schedules I and II:
E:\FR\FM\04MRN1.SGM
04MRN1
10677
Federal Register / Vol. 70, No. 42 / Friday, March 4, 2005 / Notices
Drug
Schedule
Cathinone (1235) ..........................
Methcathinone (1237) ..................
N-Ethylamphetamine (1475) ........
N,N-Dimethylamphetamine (1480)
Aminorex (1585) ...........................
4-7Methylaminorex (cis isomer)
(1590).
Gamma
hydroxybutyric
acid
(2010).
Methaqualone (2565) ...................
Alpha-Ethyltryptamine (7249) .......
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
3,4,5-Trimethoxyamphetamine
(7390).
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
2,5-Dimethoxy-4ethylamphetamine (7399).
3,4-Methylenedioxyamphetamine
(7400).
5-Methoxy-3,4methylenedioxyamphetamine
(7401).
N-Hydroxy-3,4methylendioxyamphetamine
(7402).
3,4-Methylendioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (7405).
4-Methoxyamphetamine (7411) ...
Bufotenine (7433) .........................
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
Acetyldihydrocodeine (9051) ........
Benzylmorphine (9052) ................
Codeine-N-oxide (9053) ...............
Dihydromorphine (9145) ...............
Heroin (9200) ...............................
Hydromorphinol (9301) .................
Methyldihydromorphine (9304) .....
Morphine-N-oxide (9307) .............
Normorphine (9313) .....................
Pholcodine (9314) ........................
Acetylmethadol (9601) .................
Allylprodine (9602) .......................
Alphacetylmethadol except levoalphacetylmethadol (9603).
Alphameprodine (9604) ................
Alphamethadol (9605) ..................
Betacetylmethadol (9607) ............
Betameprodine (9608) ..................
Betamethadol (9609) ....................
Betaprodine (9611) .......................
Hydroxypethidine (9627) ..............
Noracymethadol (9633) ................
Norlevorphanol (9634) ..................
Normethadone (9635) ..................
Trimeperidine (9646) ....................
Phenomorphan (9647) .................
Para-Fluorofentanyl (9812) ..........
3–Methylfentanyl (9813) ...............
VerDate jul<14>2003
19:07 Mar 03, 2005
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Jkt 205001
Drug
Schedule
Alpha-Methylfentanyl (9814) ........
Acetyl-alpha-methylfentanyl
(9815).
Beta-hydroxyfentanyl (9830) ........
Beta-hydroxy-3-methylfentanyl
(9831).
Alpha-Methylthiofentanyl (9832) ...
3–Methylthiofentanyl (9833) .........
Thiofentanyl (9835) ......................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Phenmetrazine (1631) ..................
Methylphenidate (1724) ................
Ambobarbital (2125) .....................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Nabilone
(7379)
II
1–
Phenylcyclohexylamine (7460).
Phencyclidine (7471) ....................
1–
Piperidinocyclohexanecarbonitrile (8603).
Alphaprodine (9010) .....................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Benzoylecgonine (9180) ...............
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Levomethorphan (9210) ...............
Levorphanol (9220) ......................
Isomethadone (9226) ...................
Meperidine (9230) ........................
Methadone (9250) ........................
Methadone-intermediate (9254) ...
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Racemethorphan (9732) ..............
Alfentanil (9737) ...........................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances to make reference standards
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cerilliant Corporation to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Cerilliant Corporation to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: Febuary 22, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–4205 Filed 3–3–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated September 28, 2004
and published in the Federal Register
on October 14, 2004, (69 FR 61044),
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78664, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
the basic classes of controlled
substances listed in Schedules I and II:
Drug
Cathinone (1235) ..........................
Methcathinone (1237) ..................
N-Ethylamphetamine (1475) ........
Gamma
hydroxybutyric
acid
(2010).
Ibogaine (7260) ............................
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
3,4Methylenedioxymethamphetamine (7404).
3,4Methylenedioxymethamphetamine (7405).
4-Methoxyamphetamine (7411) ...
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
Etorphine (9056) ...........................
Heroin (9200) ...............................
Pholcodine (9314) ........................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
E:\FR\FM\04MRN1.SGM
04MRN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
]]>Agencies
[Federal Register Volume 70, Number 42 (Friday, March 4, 2005)]
[Notices]
[Pages 10676-10677]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-4205]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated September 28, 2004, and published in the Federal
Register on October 14, 2004, (69 FR 61043), Cerilliant Corporation,
811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application by
renewal to the Drug Enforcement Administration (DEA) for registration
as a bulk manufacturer of the basic classes of controlled substances
listed in Schedules I and II:
[[Page 10677]]
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................... I
Methcathinone (1237)....................... I
N-Ethylamphetamine (1475).................. I
N,N-Dimethylamphetamine (1480)............. I
Aminorex (1585)............................ I
4-7Methylaminorex (cis isomer) (1590)...... I
Gamma hydroxybutyric acid (2010)........... I
Methaqualone (2565)........................ I
Alpha-Ethyltryptamine (7249)............... I
Lysergic acid diethylamide (7315).......... I
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
3,4,5-Trimethoxyamphetamine (7390)......... I
4-Bromo-2,5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
4-Methyl-2,5-dimethoxyamphetamine (7395)... I
2,5-Dimethoxyamphetamine (7396)............ I
2,5-Dimethoxy-4-ethylamphetamine (7399).... I
3,4-Methylenedioxyamphetamine (7400)....... I
5-Methoxy-3,4-methylenedioxyamphetamine I
(7401).
N-Hydroxy-3,4-methylendioxyamphetamine I
(7402).
3,4-Methylendioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405)... I
4-Methoxyamphetamine (7411)................ I
Bufotenine (7433).......................... I
Diethyltryptamine (7434)................... I
Dimethyltryptamine (7435).................. I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
Acetyldihydrocodeine (9051)................ I
Benzylmorphine (9052)...................... I
Codeine-N-oxide (9053)..................... I
Dihydromorphine (9145)..................... I
Heroin (9200).............................. I
Hydromorphinol (9301)...................... I
Methyldihydromorphine (9304)............... I
Morphine-N-oxide (9307).................... I
Normorphine (9313)......................... I
Pholcodine (9314).......................... I
Acetylmethadol (9601)...................... I
Allylprodine (9602)........................ I
Alphacetylmethadol except levo- I
alphacetylmethadol (9603).
Alphameprodine (9604)...................... I
Alphamethadol (9605)....................... I
Betacetylmethadol (9607)................... I
Betameprodine (9608)....................... I
Betamethadol (9609)........................ I
Betaprodine (9611)......................... I
Hydroxypethidine (9627).................... I
Noracymethadol (9633)...................... I
Norlevorphanol (9634)...................... I
Normethadone (9635)........................ I
Trimeperidine (9646)....................... I
Phenomorphan (9647)........................ I
Para-Fluorofentanyl (9812)................. I
3-Methylfentanyl (9813).................... I
Alpha-Methylfentanyl (9814)................ I
Acetyl-alpha-methylfentanyl (9815)......... I
Beta-hydroxyfentanyl (9830)................ I
Beta-hydroxy-3-methylfentanyl (9831)....... I
Alpha-Methylthiofentanyl (9832)............ I
3-Methylthiofentanyl (9833)................ I
Thiofentanyl (9835)........................ I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Phenmetrazine (1631)....................... II
Methylphenidate (1724)..................... II
Ambobarbital (2125)........................ II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
Glutethimide (2550)........................ II
Nabilone (7379) II 1-Phenylcyclohexylamine II
(7460).
Phencyclidine (7471)....................... II
1-Piperidinocyclohexanecarbonitrile (8603). II
Alphaprodine (9010)........................ II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Diphenoxylate (9170)....................... II
Benzoylecgonine (9180)..................... II
Ethylmorphine (9190)....................... II
Hydrocodone (9193)......................... II
Levomethorphan (9210)...................... II
Levorphanol (9220)......................... II
Isomethadone (9226)........................ II
Meperidine (9230).......................... II
Methadone (9250)........................... II
Methadone-intermediate (9254).............. II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................ II
Thebaine (9333)............................ II
Levo-alphacetylmethadol (9648)............. II
Oxymorphone (9652)......................... II
Noroxymorphone (9668)...................... II
Racemethorphan (9732)...................... II
Alfentanil (9737).......................... II
Sufentanil (9740).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances to make reference standards for distribution to
its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cerilliant Corporation to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Cerilliant Corporation to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: Febuary 22, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-4205 Filed 3-3-05; 8:45 am]
BILLING CODE 4410-09-P
